کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2474815 | 1113165 | 2014 | 7 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation](/preview/png/2474815.png)
An aerosol formulation containing 7.5 mg of R-salbutamol sulfate was developed. The aerosol was nebulized with an air-jet nebulizer, and further assessed according to the new European Medicines Agency (EMA) guidelines. A breath simulator was used for studies of delivery rate and total amount of the active ingredient at volume of 3 mL. A next generation impactor (NGI) with a cooler was used for analysis of the particle size and in vitro lung deposition rate of the active ingredient at 5 °C. The anti-asthmatic efficacy of the aerosol formulation was assessed in guinea pigs with asthma evoked by intravenous injection of histamine compared with racemic salbutamol. Our results show that this aerosol formulation of R-salbutamol sulfate met all the requirements of the new EMA guidelines for nebulizer. The efficacy of a half-dose of R-salbutamol equaled that of a normal dose of racemic salbutamol.
Drug particles will deposit in different stages of NGI which simulate the lower respiratory tract structure approximately. Also alleviation of airway hyperreactivity by inhaling R-salbutamol sulfate solution was validated both in airway resistance and in dynamic compliance of lung compared with racemic salbutamol.Figure optionsDownload as PowerPoint slide
Journal: Acta Pharmaceutica Sinica B - Volume 4, Issue 1, February 2014, Pages 79–85